ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Microbiome Modulators Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-30P5716
Home | Market Reports | Science| Biological Sciences
Global and United States Human Microbiome Modulators Market Report Forecast 2022 2028
BUY CHAPTERS

Global Human Microbiome Modulators Market Insights, Forecast to 2030

Code: QYRE-Auto-30P5716
Report
December 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
BioGaia
Chr. Hansen Holding
DowDuPont
Ingredion
ISOThrive
Jarrow Formulas
DSM
Lallemand
Sanofi

Human Microbiome Modulators Market

The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract.
Market Analysis and Insights: Global Human Microbiome Modulators Market
The global Human Microbiome Modulators market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Microbiome Modulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Microbiome Modulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Human Microbiome Modulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Human Microbiome Modulators include Bayer, BioGaia, Chr. Hansen Holding, DowDuPont, Ingredion, ISOThrive, Jarrow Formulas, DSM and Lallemand, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Human Microbiome Modulators is widely used in various fields, such as Digestive Health, Immune Health, Oral Health and Others, etc. Digestive Health provides greatest supports to the Human Microbiome Modulators industry development. In 2023, global % revenue of Human Microbiome Modulators went into Digestive Health filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Human Microbiome Modulators market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Microbiome Modulators, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Human Microbiome Modulators, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Microbiome Modulators revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Human Microbiome Modulators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Human Microbiome Modulators revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Human Microbiome Modulators Market Report

Report Metric Details
Report Name Human Microbiome Modulators Market
Segment by Type
Segment by Application
  • Digestive Health
  • Immune Health
  • Oral Health
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, BioGaia, Chr. Hansen Holding, DowDuPont, Ingredion, ISOThrive, Jarrow Formulas, DSM, Lallemand, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Human Microbiome Modulators in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Human Microbiome Modulators companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Microbiome Modulators revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Human Microbiome Modulators Market report?

Ans: The main players in the Human Microbiome Modulators Market are Bayer, BioGaia, Chr. Hansen Holding, DowDuPont, Ingredion, ISOThrive, Jarrow Formulas, DSM, Lallemand, Sanofi

What are the Application segmentation covered in the Human Microbiome Modulators Market report?

Ans: The Applications covered in the Human Microbiome Modulators Market report are Digestive Health, Immune Health, Oral Health, Others

What are the Type segmentation covered in the Human Microbiome Modulators Market report?

Ans: The Types covered in the Human Microbiome Modulators Market report are Probiotics and Creams, Prebiotics and Dietary Supplements, Drugs

Recommended Reports

Microbiome Therapeutics

Digestive Health

Probiotic Supplements

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Modulators Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Probiotics and Creams
1.2.3 Prebiotics and Dietary Supplements
1.2.4 Drugs
1.3 Market by Application
1.3.1 Global Human Microbiome Modulators Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Digestive Health
1.3.3 Immune Health
1.3.4 Oral Health
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Modulators Market Perspective (2019-2030)
2.2 Global Human Microbiome Modulators Growth Trends by Region
2.2.1 Human Microbiome Modulators Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Microbiome Modulators Historic Market Size by Region (2019-2024)
2.2.3 Human Microbiome Modulators Forecasted Market Size by Region (2025-2030)
2.3 Human Microbiome Modulators Market Dynamics
2.3.1 Human Microbiome Modulators Industry Trends
2.3.2 Human Microbiome Modulators Market Drivers
2.3.3 Human Microbiome Modulators Market Challenges
2.3.4 Human Microbiome Modulators Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Human Microbiome Modulators by Players
3.1.1 Global Human Microbiome Modulators Revenue by Players (2019-2024)
3.1.2 Global Human Microbiome Modulators Revenue Market Share by Players (2019-2024)
3.2 Global Human Microbiome Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Human Microbiome Modulators, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Human Microbiome Modulators Market Concentration Ratio
3.4.1 Global Human Microbiome Modulators Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Modulators Revenue in 2023
3.5 Global Key Players of Human Microbiome Modulators Head office and Area Served
3.6 Global Key Players of Human Microbiome Modulators, Product and Application
3.7 Global Key Players of Human Microbiome Modulators, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Modulators Breakdown Data by Type
4.1 Global Human Microbiome Modulators Historic Market Size by Type (2019-2024)
4.2 Global Human Microbiome Modulators Forecasted Market Size by Type (2025-2030)
5 Human Microbiome Modulators Breakdown Data by Application
5.1 Global Human Microbiome Modulators Historic Market Size by Application (2019-2024)
5.2 Global Human Microbiome Modulators Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Microbiome Modulators Market Size (2019-2030)
6.2 North America Human Microbiome Modulators Market Size by Type
6.2.1 North America Human Microbiome Modulators Market Size by Type (2019-2024)
6.2.2 North America Human Microbiome Modulators Market Size by Type (2025-2030)
6.2.3 North America Human Microbiome Modulators Market Share by Type (2019-2030)
6.3 North America Human Microbiome Modulators Market Size by Application
6.3.1 North America Human Microbiome Modulators Market Size by Application (2019-2024)
6.3.2 North America Human Microbiome Modulators Market Size by Application (2025-2030)
6.3.3 North America Human Microbiome Modulators Market Share by Application (2019-2030)
6.4 North America Human Microbiome Modulators Market Size by Country
6.4.1 North America Human Microbiome Modulators Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Human Microbiome Modulators Market Size by Country (2019-2024)
6.4.3 North America Human Microbiome Modulators Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Human Microbiome Modulators Market Size (2019-2030)
7.2 Europe Human Microbiome Modulators Market Size by Type
7.2.1 Europe Human Microbiome Modulators Market Size by Type (2019-2024)
7.2.2 Europe Human Microbiome Modulators Market Size by Type (2025-2030)
7.2.3 Europe Human Microbiome Modulators Market Share by Type (2019-2030)
7.3 Europe Human Microbiome Modulators Market Size by Application
7.3.1 Europe Human Microbiome Modulators Market Size by Application (2019-2024)
7.3.2 Europe Human Microbiome Modulators Market Size by Application (2025-2030)
7.3.3 Europe Human Microbiome Modulators Market Share by Application (2019-2030)
7.4 Europe Human Microbiome Modulators Market Size by Country
7.4.1 Europe Human Microbiome Modulators Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Human Microbiome Modulators Market Size by Country (2019-2024)
7.4.3 Europe Human Microbiome Modulators Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Human Microbiome Modulators Market Size (2019-2030)
8.2 China Human Microbiome Modulators Market Size by Type
8.2.1 China Human Microbiome Modulators Market Size by Type (2019-2024)
8.2.2 China Human Microbiome Modulators Market Size by Type (2025-2030)
8.2.3 China Human Microbiome Modulators Market Share by Type (2019-2030)
8.3 China Human Microbiome Modulators Market Size by Application
8.3.1 China Human Microbiome Modulators Market Size by Application (2019-2024)
8.3.2 China Human Microbiome Modulators Market Size by Application (2025-2030)
8.3.3 China Human Microbiome Modulators Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Human Microbiome Modulators Market Size (2019-2030)
9.2 Asia Human Microbiome Modulators Market Size by Type
9.2.1 Asia Human Microbiome Modulators Market Size by Type (2019-2024)
9.2.2 Asia Human Microbiome Modulators Market Size by Type (2025-2030)
9.2.3 Asia Human Microbiome Modulators Market Share by Type (2019-2030)
9.3 Asia Human Microbiome Modulators Market Size by Application
9.3.1 Asia Human Microbiome Modulators Market Size by Application (2019-2024)
9.3.2 Asia Human Microbiome Modulators Market Size by Application (2025-2030)
9.3.3 Asia Human Microbiome Modulators Market Share by Application (2019-2030)
9.4 Asia Human Microbiome Modulators Market Size by Region
9.4.1 Asia Human Microbiome Modulators Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Human Microbiome Modulators Market Size by Region (2019-2024)
9.4.3 Asia Human Microbiome Modulators Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Type
10.2.1 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Human Microbiome Modulators Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Application
10.3.1 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Human Microbiome Modulators Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country
10.4.1 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Human Microbiome Modulators Introduction
11.1.4 Bayer Revenue in Human Microbiome Modulators Business (2019-2024)
11.1.5 Bayer Recent Developments
11.2 BioGaia
11.2.1 BioGaia Company Details
11.2.2 BioGaia Business Overview
11.2.3 BioGaia Human Microbiome Modulators Introduction
11.2.4 BioGaia Revenue in Human Microbiome Modulators Business (2019-2024)
11.2.5 BioGaia Recent Developments
11.3 Chr. Hansen Holding
11.3.1 Chr. Hansen Holding Company Details
11.3.2 Chr. Hansen Holding Business Overview
11.3.3 Chr. Hansen Holding Human Microbiome Modulators Introduction
11.3.4 Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2019-2024)
11.3.5 Chr. Hansen Holding Recent Developments
11.4 DowDuPont
11.4.1 DowDuPont Company Details
11.4.2 DowDuPont Business Overview
11.4.3 DowDuPont Human Microbiome Modulators Introduction
11.4.4 DowDuPont Revenue in Human Microbiome Modulators Business (2019-2024)
11.4.5 DowDuPont Recent Developments
11.5 Ingredion
11.5.1 Ingredion Company Details
11.5.2 Ingredion Business Overview
11.5.3 Ingredion Human Microbiome Modulators Introduction
11.5.4 Ingredion Revenue in Human Microbiome Modulators Business (2019-2024)
11.5.5 Ingredion Recent Developments
11.6 ISOThrive
11.6.1 ISOThrive Company Details
11.6.2 ISOThrive Business Overview
11.6.3 ISOThrive Human Microbiome Modulators Introduction
11.6.4 ISOThrive Revenue in Human Microbiome Modulators Business (2019-2024)
11.6.5 ISOThrive Recent Developments
11.7 Jarrow Formulas
11.7.1 Jarrow Formulas Company Details
11.7.2 Jarrow Formulas Business Overview
11.7.3 Jarrow Formulas Human Microbiome Modulators Introduction
11.7.4 Jarrow Formulas Revenue in Human Microbiome Modulators Business (2019-2024)
11.7.5 Jarrow Formulas Recent Developments
11.8 DSM
11.8.1 DSM Company Details
11.8.2 DSM Business Overview
11.8.3 DSM Human Microbiome Modulators Introduction
11.8.4 DSM Revenue in Human Microbiome Modulators Business (2019-2024)
11.8.5 DSM Recent Developments
11.9 Lallemand
11.9.1 Lallemand Company Details
11.9.2 Lallemand Business Overview
11.9.3 Lallemand Human Microbiome Modulators Introduction
11.9.4 Lallemand Revenue in Human Microbiome Modulators Business (2019-2024)
11.9.5 Lallemand Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Human Microbiome Modulators Introduction
11.10.4 Sanofi Revenue in Human Microbiome Modulators Business (2019-2024)
11.10.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Bayer
BioGaia
Chr. Hansen Holding
DowDuPont
Ingredion
ISOThrive
Jarrow Formulas
DSM
Lallemand
Sanofi
List of Tables
    Table 1. Global Human Microbiome Modulators Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Probiotics and Creams
    Table 3. Key Players of Prebiotics and Dietary Supplements
    Table 4. Key Players of Drugs
    Table 5. Global Human Microbiome Modulators Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Human Microbiome Modulators Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Human Microbiome Modulators Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Human Microbiome Modulators Market Share by Region (2019-2024)
    Table 9. Global Human Microbiome Modulators Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Human Microbiome Modulators Market Share by Region (2025-2030)
    Table 11. Human Microbiome Modulators Market Trends
    Table 12. Human Microbiome Modulators Market Drivers
    Table 13. Human Microbiome Modulators Market Challenges
    Table 14. Human Microbiome Modulators Market Restraints
    Table 15. Global Human Microbiome Modulators Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Human Microbiome Modulators Revenue Share by Players (2019-2024)
    Table 17. Global Top Human Microbiome Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Modulators as of 2023)
    Table 18. Global Human Microbiome Modulators Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Human Microbiome Modulators Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Human Microbiome Modulators, Headquarters and Area Served
    Table 21. Global Key Players of Human Microbiome Modulators, Product and Application
    Table 22. Global Key Players of Human Microbiome Modulators, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Human Microbiome Modulators Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Human Microbiome Modulators Revenue Market Share by Type (2019-2024)
    Table 26. Global Human Microbiome Modulators Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Human Microbiome Modulators Revenue Market Share by Type (2025-2030)
    Table 28. Global Human Microbiome Modulators Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Human Microbiome Modulators Revenue Share by Application (2019-2024)
    Table 30. Global Human Microbiome Modulators Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Human Microbiome Modulators Revenue Share by Application (2025-2030)
    Table 32. North America Human Microbiome Modulators Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Human Microbiome Modulators Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Human Microbiome Modulators Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Human Microbiome Modulators Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Human Microbiome Modulators Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Human Microbiome Modulators Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Human Microbiome Modulators Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Human Microbiome Modulators Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Human Microbiome Modulators Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Human Microbiome Modulators Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Human Microbiome Modulators Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Human Microbiome Modulators Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Human Microbiome Modulators Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Human Microbiome Modulators Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Human Microbiome Modulators Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Human Microbiome Modulators Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Human Microbiome Modulators Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Human Microbiome Modulators Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Human Microbiome Modulators Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Human Microbiome Modulators Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Human Microbiome Modulators Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Human Microbiome Modulators Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Human Microbiome Modulators Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Human Microbiome Modulators Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Human Microbiome Modulators Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Human Microbiome Modulators Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Bayer Company Details
    Table 65. Bayer Business Overview
    Table 66. Bayer Human Microbiome Modulators Product
    Table 67. Bayer Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 68. Bayer Recent Developments
    Table 69. BioGaia Company Details
    Table 70. BioGaia Business Overview
    Table 71. BioGaia Human Microbiome Modulators Product
    Table 72. BioGaia Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 73. BioGaia Recent Developments
    Table 74. Chr. Hansen Holding Company Details
    Table 75. Chr. Hansen Holding Business Overview
    Table 76. Chr. Hansen Holding Human Microbiome Modulators Product
    Table 77. Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 78. Chr. Hansen Holding Recent Developments
    Table 79. DowDuPont Company Details
    Table 80. DowDuPont Business Overview
    Table 81. DowDuPont Human Microbiome Modulators Product
    Table 82. DowDuPont Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 83. DowDuPont Recent Developments
    Table 84. Ingredion Company Details
    Table 85. Ingredion Business Overview
    Table 86. Ingredion Human Microbiome Modulators Product
    Table 87. Ingredion Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 88. Ingredion Recent Developments
    Table 89. ISOThrive Company Details
    Table 90. ISOThrive Business Overview
    Table 91. ISOThrive Human Microbiome Modulators Product
    Table 92. ISOThrive Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 93. ISOThrive Recent Developments
    Table 94. Jarrow Formulas Company Details
    Table 95. Jarrow Formulas Business Overview
    Table 96. Jarrow Formulas Human Microbiome Modulators Product
    Table 97. Jarrow Formulas Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 98. Jarrow Formulas Recent Developments
    Table 99. DSM Company Details
    Table 100. DSM Business Overview
    Table 101. DSM Human Microbiome Modulators Product
    Table 102. DSM Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 103. DSM Recent Developments
    Table 104. Lallemand Company Details
    Table 105. Lallemand Business Overview
    Table 106. Lallemand Human Microbiome Modulators Product
    Table 107. Lallemand Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 108. Lallemand Recent Developments
    Table 109. Sanofi Company Details
    Table 110. Sanofi Business Overview
    Table 111. Sanofi Human Microbiome Modulators Product
    Table 112. Sanofi Revenue in Human Microbiome Modulators Business (2019-2024) & (US$ Million)
    Table 113. Sanofi Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Human Microbiome Modulators Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Human Microbiome Modulators Market Share by Type: 2023 VS 2030
    Figure 3. Probiotics and Creams Features
    Figure 4. Prebiotics and Dietary Supplements Features
    Figure 5. Drugs Features
    Figure 6. Global Human Microbiome Modulators Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Human Microbiome Modulators Market Share by Application: 2023 VS 2030
    Figure 8. Digestive Health Case Studies
    Figure 9. Immune Health Case Studies
    Figure 10. Oral Health Case Studies
    Figure 11. Others Case Studies
    Figure 12. Human Microbiome Modulators Report Years Considered
    Figure 13. Global Human Microbiome Modulators Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Human Microbiome Modulators Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Human Microbiome Modulators Market Share by Region: 2023 VS 2030
    Figure 16. Global Human Microbiome Modulators Market Share by Players in 2023
    Figure 17. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Modulators as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Human Microbiome Modulators Revenue in 2023
    Figure 19. North America Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Human Microbiome Modulators Market Share by Type (2019-2030)
    Figure 21. North America Human Microbiome Modulators Market Share by Application (2019-2030)
    Figure 22. North America Human Microbiome Modulators Market Share by Country (2019-2030)
    Figure 23. United States Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Human Microbiome Modulators Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Human Microbiome Modulators Market Share by Type (2019-2030)
    Figure 27. Europe Human Microbiome Modulators Market Share by Application (2019-2030)
    Figure 28. Europe Human Microbiome Modulators Market Share by Country (2019-2030)
    Figure 29. Germany Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Human Microbiome Modulators Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Human Microbiome Modulators Market Share by Type (2019-2030)
    Figure 37. China Human Microbiome Modulators Market Share by Application (2019-2030)
    Figure 38. Asia Human Microbiome Modulators Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Human Microbiome Modulators Market Share by Type (2019-2030)
    Figure 40. Asia Human Microbiome Modulators Market Share by Application (2019-2030)
    Figure 41. Asia Human Microbiome Modulators Market Share by Region (2019-2030)
    Figure 42. Japan Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Human Microbiome Modulators Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Human Microbiome Modulators Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Human Microbiome Modulators Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Human Microbiome Modulators Market Share by Country (2019-2030)
    Figure 52. Brazil Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Human Microbiome Modulators Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Bayer Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 59. BioGaia Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 60. Chr. Hansen Holding Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 61. DowDuPont Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 62. Ingredion Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 63. ISOThrive Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 64. Jarrow Formulas Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 65. DSM Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 66. Lallemand Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 67. Sanofi Revenue Growth Rate in Human Microbiome Modulators Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Human Microbiome Analysis Market Research Report 2024
Global Gut Microbiome Market Research Report 2024
Human Microbiome Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Microbiome Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Regulators in Human Body Market Research Report 2024
Global Skin Microbiome Modulator Market Research Report 2025
Global Microbiome Therapies Market Research Report 2024
Agriculture Microbiome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Crop Microbiome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Microbiome Sequencing Services Market Research Report 2024
Global Gut Microbiota Market Research Report 2024
Global Microbiome Drugs Market Research Report 2024
Global Human Microbiome Sequencing Market Research Report 2024
Global Microbiomes Market Research Report 2024
Global Human Microbiome Sequencing Technology Market Research Report 2024
Global Direct to Consumer Microbiome Analyzing Market Insights Forecast to 2030
Global Microbial Mass Spectrometry Market Insights Forecast to 2030
Global Microbiome Sample Preparation Technology Market Research Report 2024
Global Microbiome Cosmetic Market Research Report 2025
Global Cancer Microbiome Market Research Report 2024

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions